Adele Wang is a seasoned scientist with expertise in immuno-oncology and immune modulation, currently serving as a Principal Scientist II at Gilead Sciences since September 2015, where various roles progressed from Research Scientist to Principal Scientist II, focusing on targets for immuno-oncology therapeutics. Prior experience includes a position as a Postdoctoral Research Fellow at Merck, examining the cellular and molecular mechanisms of cancer therapy, and an extensive research background at The University of British Columbia, where Adele conducted significant work on gene signatures in type 1 diabetes and the functional characterization of regulatory T cells as part of a PhD in Experimental Medicine. Educational qualifications include a PhD from The University of British Columbia in 2012 and a BSc in Microbiology and Immunology from the same institution in 2007.
This person is not in the org chart
This person is not in any teams
This person is not in any offices